Ensysce Biosciences, Inc. (ENSC) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Ensysce Biosciences, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.23x | -1.78x | -3.39x | -1.00x | -48.88x | 3515272.39x |
| P/B Ratio | 0.00x | 3.83x | -111.50x | -6.54x | -180.44x | -30984.03x |
| P/S Ratio | 0.46x | 2.73x | 16.14x | 9.63x | 402.58x | 50763.52x |
| Profitability | ||||||
| Gross Margin | 0.0% | -38.6% | -240.1% | -686.1% | 100.0% | 100.0% |
| Operating Margin | -202.1% | -129.2% | -480.4% | -959.9% | -562.7% | -41.0% |
| Net Margin | -200.8% | -153.3% | -475.7% | -957.9% | -823.6% | 1.4% |
| EBITDA Margin | -200.3% | -129.2% | -480.4% | -959.9% | -734.3% | 21.2% |
| Liquidity | ||||||
| Current Ratio | 1.59x | 2.42x | 0.69x | 0.56x | 0.95x | 0.05x |
| Quick Ratio | 1.59x | 2.42x | 0.69x | 0.56x | 0.98x | 0.05x |
| Leverage | ||||||
| Debt/Equity | 0.10x | 0.08x | -2.65x | -1.19x | -2.19x | -0.66x |
YoY = year-over-year change. Source: FMP..